FACTS ABOUT GSMTX4 TFA (1209500-46-8 FREE BASE) REVEALED

Pharmacological inhibition from the ataxia telangiectasia and Rad3-related protein serine/threonine kinase (ATR; also referred to as FRAP-related protein (FRP1)) has emerged as being a promising system for cancer therapy that exploits artificial lethal interactions with proteins involved in DNA injury mend, overcomes resistance to other therapies a